Neostigmine Solution For Injection 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Neostigmine: Solution for injection (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

NEOSTIGMINE (nee oh STIG meen) can help to correct muscle strength. It is used to treat myasthenia gravis.

In-Depth Information
Select a Medication

Neostigmine Methylsulfate 0.5mg/ml Solution for Injection

NDC: 633230382
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Myasthenia Gravis, Neuromuscular Blockade Reversal, Ileus, Urinary Retention

Sometimes used for but not FDA approved for the following conditions:
Acute Colonic Pseudo-obstruction, Myasthenia Gravis Diagnosis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Neostigmine Methylsulfate 0.5mg/ml Solution for Injection

Reported Side Effects for Neostigmine Methylsulfate 0.5mg/ml Solution for Injection

Shivering Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Slow Heart Beat Incidence:
>1.0%*
Severity: SEVERE
Onset: RAPID
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Inability To Sleep Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Dry Mouth Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Neostigmine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5